Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis. J of Skin [Internet]. 2023 Mar. 13 [cited 2026 May 1];7(2):s133. Available from: https://skin.dermsquared.com/skin/article/view/1986